ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 227 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $287,909 | -87.4% | 27,446 | -84.9% | 0.00% | -86.7% |
Q2 2023 | $2,287,316 | -75.7% | 181,533 | -74.9% | 0.02% | -73.7% |
Q1 2023 | $9,424,580 | +248.4% | 722,190 | +370.9% | 0.06% | +256.2% |
Q4 2022 | $2,705,306 | -34.1% | 153,362 | -43.1% | 0.02% | -30.4% |
Q3 2022 | $4,103,000 | -13.1% | 269,376 | -15.4% | 0.02% | -20.7% |
Q2 2022 | $4,722,000 | +58.6% | 318,415 | +140.8% | 0.03% | +16.0% |
Q1 2022 | $2,977,000 | +50.5% | 132,209 | +23.4% | 0.02% | +31.6% |
Q4 2021 | $1,978,000 | -47.7% | 107,182 | -62.1% | 0.02% | -60.4% |
Q3 2021 | $3,780,000 | +201.2% | 282,729 | +317.0% | 0.05% | +242.9% |
Q2 2021 | $1,255,000 | -39.1% | 67,796 | -50.6% | 0.01% | -46.2% |
Q1 2021 | $2,061,000 | +61.3% | 137,248 | +55.0% | 0.03% | +44.4% |
Q4 2020 | $1,278,000 | -13.1% | 88,533 | -51.0% | 0.02% | -18.2% |
Q3 2020 | $1,471,000 | +550.9% | 180,658 | +441.2% | 0.02% | +450.0% |
Q2 2020 | $226,000 | -63.3% | 33,381 | -61.8% | 0.00% | -76.5% |
Q1 2020 | $615,000 | -61.1% | 87,424 | -45.7% | 0.02% | -41.4% |
Q4 2019 | $1,579,000 | +1736.0% | 160,901 | +1949.7% | 0.03% | +1350.0% |
Q3 2019 | $86,000 | -76.9% | 7,850 | -75.5% | 0.00% | -71.4% |
Q2 2019 | $373,000 | -39.2% | 32,094 | -50.0% | 0.01% | -65.0% |
Q1 2019 | $613,000 | -4.7% | 64,219 | -3.7% | 0.02% | -33.3% |
Q4 2018 | $643,000 | -0.8% | 66,657 | +46.6% | 0.03% | -14.3% |
Q3 2018 | $648,000 | +25.3% | 45,469 | +5.5% | 0.04% | +34.6% |
Q2 2018 | $517,000 | +3.2% | 43,095 | +6.2% | 0.03% | -10.3% |
Q1 2018 | $501,000 | -21.1% | 40,591 | -7.1% | 0.03% | -14.7% |
Q4 2017 | $635,000 | +44.3% | 43,673 | +41.1% | 0.03% | +36.0% |
Q3 2017 | $440,000 | +43900.0% | 30,953 | +67189.1% | 0.02% | – |
Q2 2017 | $1,000 | -99.7% | 46 | -99.8% | 0.00% | -100.0% |
Q1 2017 | $295,000 | -11.9% | 23,302 | -28.9% | 0.02% | -22.2% |
Q4 2016 | $335,000 | -36.6% | 32,775 | -18.2% | 0.03% | -20.6% |
Q3 2016 | $528,000 | +1000.0% | 40,066 | +954.4% | 0.03% | +1033.3% |
Q2 2016 | $48,000 | -97.1% | 3,800 | -96.9% | 0.00% | -96.8% |
Q1 2016 | $1,628,000 | +1689.0% | 123,230 | +1583.0% | 0.09% | +1760.0% |
Q3 2015 | $91,000 | -91.3% | 7,322 | -90.5% | 0.01% | -90.2% |
Q2 2015 | $1,052,000 | +1095.5% | 76,924 | +940.4% | 0.05% | +1175.0% |
Q1 2015 | $88,000 | -89.3% | 7,394 | -87.9% | 0.00% | -92.0% |
Q3 2014 | $821,000 | +517.3% | 61,165 | +640.2% | 0.05% | +525.0% |
Q2 2014 | $133,000 | – | 8,263 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |